Table 2.
Association between adipocytokines and GDM risk (24-28 weeks).
| Unadjusted OR (95% CI) | Adjusted OR (95% CI) | ||
|---|---|---|---|
| IL-10 (pg/mL) | 0.18 (0.07-0.45)∗ | 0.17 (0.06-0.48)∗ | |
| °p value | <0.001 | 0.001 | |
| IL-4 (pg/mL) | 0.98 (0.96-1.01) | 0.98 (0.95-1.00) | |
| IL-6 (pg/mL) | 1.03 (0.82-1.30) | 1.03 (0.79-1.33) | |
| CRP (ng/mL) | 1.0 (1.0-1.01) | 1.0 (1.0-1.01) | |
| SPARC (μg/mL) | 0.44 (0.16-1.20) | 0.12 (0.16-1.24) | |
| AFABP (ng/mL) | |||
| Quartile 1 | X < 4.90 | Referent | Referent |
| Quartile 2 | 4.90 < X < 7.57 | 2.02 (0.62-6.55) | 1.92 (0.55-6.67) |
| Quartile 3 | 7.57 < X < 10.09 | 0.93 (0.29-3.0) | 0.92 (0.27-3.11) |
| Quartile 4 | X > 10.09 | 3.68 (1.06-12.77)∗ | 1.11 (1.00-1.22)∗ |
| p value | 0.04 | 0.03 | |
| Chemerin (ng/mL) | |||
| Tertile 1 | <8.03 | 3.6 (1.3-10.4) | 4.5 (1.4-14.0) |
| Tertile 2 | 8.0 ≤ X < 10.2 | 1.2 (0.4-3.2) | 1.1 (0.4-3.0) |
| Tertile 3 | ≥10.2 | Referent | Referent |
| p value | <0.001∗ | 0.001∗ | |
OR (95% CI) adjusted for maternal age, gestational age, and BMI. ∗p value < 0.05.